BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6994395)

  • 21. [Multipe sensitization in experimental syphilis in rabbits (An investigation on the mechanism of gumma formation)].
    Yano T
    Nihon Saikingaku Zasshi; 1969; 24(7):345-53. PubMed ID: 4902128
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of anti-Treponema pallidum antibodies in normal rabbits by RNA-immuno-carrier extraxcted from serum of syphilitic rabbits.
    Michelazzi L; Baldini I; Marinari UM; Novelli A; Nanni G
    Experientia; 1967 Mar; 23(3):207-8. PubMed ID: 4861771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on fluorescence-microscopy differentiation of antibodies in syphilis].
    Müller F; Prodanovic S
    Arch Hyg Bakteriol; 1968 Jan; 152(1):76-8. PubMed ID: 4884479
    [No Abstract]   [Full Text] [Related]  

  • 24. [Causes and methods of the elimination of "nonspecific" immunofluorescence of Treponema pallidum. I. Factors responsible for nonspecific fluorescence of Treponema pallidum].
    Ruczkowska J
    Przegl Dermatol; 1982; 69(1-2):91-5. PubMed ID: 6758046
    [No Abstract]   [Full Text] [Related]  

  • 25. Attempt to protect rabbits against experimental syphilis by passive immunization.
    Sepetjian M; Salussola D; Thivolet J
    Br J Vener Dis; 1973 Aug; 49(4):335-7. PubMed ID: 4580018
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Vaccines for syphilis.
    Br Med J; 1974 May; 2(5915):346-7. PubMed ID: 4599147
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the Treponema reactions in the cerebrospinal fluid and serum of patients with syphilis].
    Manikowska-Lesińska W; Chodynicka B; Puciło K
    Przegl Dermatol; 1981; 68(3):335-41. PubMed ID: 7029663
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunity in syphilis. Studies in active immunity.
    Al-Samarrai HT; Henderson WG
    Br J Vener Dis; 1976 Oct; 52(5):300-8. PubMed ID: 791454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-specific reaction in mice inoculated with Treponema pallidum].
    Ota Y
    Rinsho Byori; 1972 Feb; 20(2):123-6. PubMed ID: 4555055
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cause and methods of elimination of nonspecific immunofluorescence of Treponema pallidum. Role of human complement in the Treponema pallidum immunofluorescence reaction].
    Ruczkowska J
    Przegl Dermatol; 1981; 68(2):181-7. PubMed ID: 7029658
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nonspecific positive results of serodiagnostic reactions for syphilis and the possibility of their recognition].
    Ehrmann G
    Wien Klin Wochenschr; 1969 Mar; 81(12):213-7. PubMed ID: 4890964
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence that immunization with TP0751, a bipartite Treponema pallidum lipoprotein with an intrinsically disordered region and lipocalin fold, fails to protect in the rabbit model of experimental syphilis.
    Luthra A; Montezuma-Rusca JM; La Vake CJ; LeDoyt M; Delgado KN; Davenport TC; Fiel-Gan M; Caimano MJ; Radolf JD; Hawley KL
    PLoS Pathog; 2020 Sep; 16(9):e1008871. PubMed ID: 32936831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
    Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
    Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunity aspects in syphilis].
    Ionescu D; Georgescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1979; 24(2):81-96. PubMed ID: 379962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of immunological reaction of the cellular type in protection of the body against Treponema pallidum infection].
    Podwińska J
    Przegl Dermatol; 1985; 72(2):113-23. PubMed ID: 3901125
    [No Abstract]   [Full Text] [Related]  

  • 36. [Method of using ultrasonicated treponema antigen].
    Pavlovskaia VE; Rezaĭkina AV
    Vestn Dermatol Venerol; 1976 Dec; (12):32-4. PubMed ID: 799434
    [No Abstract]   [Full Text] [Related]  

  • 37. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
    Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
    Front Immunol; 2021; 12():759474. PubMed ID: 34899710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Supplementary findings on methods for the serodiagnosis of syphilis. 1. Serological specificity of the antigen of Treponema pallidum Reiter strain].
    Tomizawa T; Kasamatsu S; Yamaya S; Yamada M
    Nihon Saikingaku Zasshi; 1966 May; 21(5):251-5. PubMed ID: 5333565
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological patterns in syphilis including the question of antibodies. With reference to recent experimental studies].
    Grossmann H; Oeynhausen B
    Hautarzt; 1970 Jun; 21(6):245-52. PubMed ID: 4938729
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of a vaccine for syphilis.
    Musher DM; Baughn RE; Lapushin RW; Knox JM; Duncan WC
    Sex Transm Dis; 1977; 4(4):163-6. PubMed ID: 339377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.